Risk of Pancreatitis After Endoscopic Ultrasound-Guided Fine-Needle Aspiration of Pancreatic Cystic Lesions: A Systematic Review and Meta-Analysis
- 5 July 2024
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 119 (11) , 2174-2186
Abstract
INTRODUCTION: Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is frequently used to risk-stratify pancreatic cystic lesions (PCLs). Rising PCL incidence and developments in tissue acquisition and specimen analysis necessitate updated appraisal of EUS-FNA safety, particularly the risk of postprocedure pancreatitis, the most common EUS-FNA-related adverse event. Our systematic review aims to accurately quantify the risk of EUS-FNA-related pancreatitis to best inform decisions regarding EUS-FNA's optimal role in PCL workup. METHODS: We performed systematic searches in 4 databases from inception to April 2024 for original English-language studies investigating EUS-FNA-related pancreatitis. We extracted data on demographics and EUS-FNA-related pancreatitis risk, severity, and risk factors. These were meta-analyzed through the DerSimonian Laird Method using a random-effects model. Meta-regression of pancreatitis risk was performed to delineate associations with clinical and procedural characteristics. RESULTS: Sixty-four studies comprised 8,086 patients and reported 110 EUS-FNA-related pancreatitis events. Pooled risk of EUS-FNA-related pancreatitis was 1.4% (95% confidence intervals, −0.8% to 3.5%; I 2 = 0.00), which was predominantly of mild severity (67%) and uniformly nonfatal. Pancreatitis risk lacked significant association with sample size, age, sex, cyst size, needle caliber, or passes, although we noted trends toward higher risk in studies published after 2015, those using higher gauge needles (19 G vs 22 G/25 G), and those performing EUS-guided through-the-needle biopsy. DISCUSSION: We note with high certainty that pancreatitis after EUS-FNA of PCLs is infrequent and mild in severity with no mortality in the included cohort. EUS-guided through-the-needle biopsy may serve as a significant risk factor for EUS-FNA-related pancreatitis risk; however, further studies are needed to delineate other predisposing characteristics.Keywords
This publication has 102 references indexed in Scilit:
- State-of-the-Art Update of Pancreatic CystsDigestive Diseases and Sciences, 2021
- EUS is accurate in characterizing pancreatic cystic lesions; a prospective comparison with cross-sectional imaging in resected casesSurgical Endoscopy, 2020
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessmentsResearch Synthesis Methods, 2020
- Cytology with rapid on‐site examination (ROSE) does not improve diagnostic yield of EUS‐FNA of pancreatic cystic lesionsDiagnostic Cytopathology, 2019
- Needle-Based Confocal Laser Endomicroscopy for Evaluation of Cystic Neoplasms of the PancreasDigestive Diseases and Sciences, 2017
- A comparison of the results of prospective and retrospective cohort studies in the field of digestive surgerySurgery Today, 2017
- Factors Determining Diagnostic Yield of Endoscopic Ultrasound Guided Fine-Needle Aspiration for Pancreatic Cystic Lesions: A Multicentre Asian StudyDigestive Diseases and Sciences, 2013
- EchoBrush may be superior to standard EUS‐guided FNA in the evaluation of cystic lesions of the pancreasCancer Cytopathology, 2011
- The role of endoscopic ultrasound and endoscopic ultrasound‐guided fine‐needle aspiration in distinguishing pancreatic cystic lesionsDiagnostic Cytopathology, 2006
- A Clinically Based Classification System for Acute PancreatitisArchives of Surgery, 1993